These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9616313)

  • 1. Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers.
    Emmanuel AV; Kamm MA; Roy AJ; Antonelli K
    Gut; 1998 Apr; 42(4):511-6. PubMed ID: 9616313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers.
    Poen AC; Felt-Bersma RJ; Van Dongen PA; Meuwissen SG
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1493-7. PubMed ID: 10571606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.
    Bouras EP; Camilleri M; Burton DD; McKinzie S
    Gut; 1999 May; 44(5):682-6. PubMed ID: 10205205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prucalopride, a systemic enterokinetic, for the treatment of constipation.
    Emmanuel AV; Roy AJ; Nicholls TJ; Kamm MA
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1347-56. PubMed ID: 12144586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.
    Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ
    Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
    Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit.
    Appel S; Kumle A; Meier R
    Clin Pharmacol Ther; 1997 Nov; 62(5):546-55. PubMed ID: 9390111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans.
    Camilleri M; Vazquez-Roque MI; Burton D; Ford T; McKinzie S; Zinsmeister AR; Druzgala P
    Neurogastroenterol Motil; 2007 Jan; 19(1):30-8. PubMed ID: 17187586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.
    Grudell AB; Camilleri M; Jensen KL; Foxx-Orenstein AE; Burton DD; Ryks MD; Baxter KL; Cox DS; Dukes GE; Kelleher DL; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1114-9. PubMed ID: 18372395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function.
    Odunsi-Shiyanbade ST; Camilleri M; McKinzie S; Burton D; Carlson P; Busciglio IA; Lamsam J; Singh R; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):159-65. PubMed ID: 19879973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers.
    Houghton LA; Foster JM; Whorwell PJ
    Aliment Pharmacol Ther; 2000 Jun; 14(6):775-82. PubMed ID: 10848662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans.
    Bharucha AE; Camilleri M; Haydock S; Ferber I; Burton D; Cooper S; Tompson D; Fitzpatrick K; Higgins R; Zinsmeister AR
    Gut; 2000 Nov; 47(5):667-74. PubMed ID: 11034583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects.
    Bharucha AE; Seide B; Guan Z; Andrews CN; Zinsmeister AR
    Neurogastroenterol Motil; 2008 Jun; 20(6):643-8. PubMed ID: 18312543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation.
    Iturrino J; Camilleri M; Wong BS; Linker Nord SJ; Burton D; Zinsmeister AR
    Aliment Pharmacol Ther; 2013 Apr; 37(8):776-85. PubMed ID: 23451764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.
    Veysey MJ; Malcolm P; Mallet AI; Jenkins PJ; Besser GM; Murphy GM; Dowling RH
    Gut; 2001 Dec; 49(6):828-34. PubMed ID: 11709518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial.
    Acosta A; Camilleri M; Kolar G; Iturrino J; Szarka LA; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR; Spence SC; Gottesdiener K; Bouras EP; Vazquez-Roque MI
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2312-9.e1. PubMed ID: 26001337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin as a prokinetic agent in preterm infants.
    Costalos C; Gounaris A; Varhalama E; Kokori F; Alexiou N; Kolovou E
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):23-5. PubMed ID: 11753159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.